RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Citryll

Citryll

Citryll is pioneering treatments for immune-mediated inflammatory diseases targeting Neutrophil Extracellular Traps with CIT-013.

Latest funding

$92.5M Series B+ ·

Led by Forbion Capital Partners · Source: fundraisingfox.com

Total raised: $113.38M across 2 sourced rounds

All 2 rounds ↓
Website: citryll.com.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biopharma, Biotechnology, Medical, Medical Device, Neuroscience.
Stage: Series B+.
Based in: Oss, The Netherlands.
Founded: 2015.
Total raised: $113.38M in 2 sourced rounds.
Last round: Dec 9, 2024 · 707 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredSep 27, 2012 (14 years old)

Funding rounds

DateRoundAmountLeadSource
Series B+$92.5MFForbion Capital Partnersfundraisingfox.com
Series B+$20.88MBBioGeneration Venturesfinsmes.com

Timeline

  1. Website created

Founders and team

Investors

Companies like Citryll

Other companies backed by Forbion Capital Partners

Forbion Capital Partners portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/citryll (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy